Education
About Us
Working with TipRanks
Follow Us
Avanos Medical, Inc. (AVNS)
:AVNS
Earnings Data
Report Date
Feb 24, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.25Last Year’s EPS
0.43Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in the Specialty Nutrition Systems segment and successful strategic moves, such as the acquisition of Nexus Medical. However, challenges with tariffs, flat growth in certain segments, and increased capital expenditures were notable concerns.Company Guidance
Specialty Nutrition Systems Segment Growth
The SNS segment showed strong performance with each business delivering double-digit and above-market growth. Specifically, organic sales were up 10% compared to a year ago.
Successful Divestiture and Acquisition
Avanos divested its hyaluronic acid business and acquired Nexus Medical, expanding its presence in neonatal and pediatric settings. The acquisition is expected to be immediately accretive to both revenue growth and earnings per share.
Improved Financial Metrics
Net sales reached approximately $178 million with an adjusted EBITDA of $20 million, an adjusted gross margin of 52.8%, and adjusted SG&A as a percentage of revenue of 40.6%.
Cost Improvement Initiatives
Avanos anticipates delivering $15 million to $20 million of run rate annualized incremental cost savings by the end of 2026.
Raised Full-Year Financial Guidance
Avanos raised and narrowed its full-year revenue estimates to $690 million to $700 million and adjusted EPS estimate to $0.85 to $0.95 per share.
AVNS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AVNS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $11.30 | $10.66 | -5.66% |
Aug 05, 2025 | $11.25 | $9.89 | -12.09% |
May 06, 2025 | $12.19 | $12.85 | +5.41% |
Feb 26, 2025 | $15.56 | $15.62 | +0.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Avanos Medical, Inc. (AVNS) report earnings?
Avanos Medical, Inc. (AVNS) is schdueled to report earning on Feb 24, 2026, Before Open (Confirmed).
What is Avanos Medical, Inc. (AVNS) earnings time?
Avanos Medical, Inc. (AVNS) earnings time is at Feb 24, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AVNS EPS forecast?
AVNS EPS forecast for the fiscal quarter 2025 (Q4) is 0.25.